260 related articles for article (PubMed ID: 26847210)
1. Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.
Wen X; Wang N; Zhang F; Dong C
Mol Med Rep; 2016 Mar; 13(3):2885-91. PubMed ID: 26847210
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase overexpression and its impact on human osteosarcoma.
Ren K; Lu X; Yao N; Chen Y; Yang A; Chen H; Zhang J; Wu S; Shi X; Wang C; Sun X
Oncotarget; 2015 Oct; 6(31):31085-103. PubMed ID: 26393679
[TBL] [Abstract][Full Text] [Related]
3. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
4. Effect of the PTEN gene on adhesion, invasion and metastasis of osteosarcoma cells.
Hu Y; Xu S; Jin W; Yi Q; Wei W
Oncol Rep; 2014 Oct; 32(4):1741-7. PubMed ID: 25069680
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.
Huang J; Zheng DL; Qin FS; Cheng N; Chen H; Wan BB; Wang YP; Xiao HS; Han ZG
J Clin Invest; 2010 Jan; 120(1):223-41. PubMed ID: 20038795
[TBL] [Abstract][Full Text] [Related]
6. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of SCARA5 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppression of the PDGF signaling pathway.
Zhao J; Jian L; Zhang L; Ding T; Li X; Cheng D; Niu S; Sun L; Li E; Liu S; Jiang Y; Liu L
Mol Med Rep; 2016 May; 13(5):4455-60. PubMed ID: 27035566
[TBL] [Abstract][Full Text] [Related]
8. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis.
Yan N; Zhang S; Yang Y; Cheng L; Li C; Dai L; Dai L; Zhang X; Fan P; Tian H; Wang R; Chen X; Su X; Li Y; Zhang J; Du T; Wei Y; Deng H
Cancer Sci; 2012 Sep; 103(9):1631-9. PubMed ID: 22642751
[TBL] [Abstract][Full Text] [Related]
10. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.
Wang J; Wang S; Chen L; Tan J
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818
[TBL] [Abstract][Full Text] [Related]
11. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
12. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
13. SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.
You K; Su F; Liu L; Lv X; Zhang J; Zhang Y; Liu B
Mol Cell Biochem; 2017 Nov; 435(1-2):47-58. PubMed ID: 28497372
[TBL] [Abstract][Full Text] [Related]
14. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
15. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
16. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
17. SCARA5 as a downstream factor of PCAT29, inhibits proliferation, migration, and invasion of bladder cancer.
Lu XS; Huang ML; Chen LB; Liu SC; Huang ZX; Liu SM
Genomics; 2023 Sep; 115(5):110667. PubMed ID: 37315873
[TBL] [Abstract][Full Text] [Related]
18. Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.
Cheng G; Gao F; Sun X; Bi H; Zhu Y
Mol Med Rep; 2016 Oct; 14(4):3199-205. PubMed ID: 27572907
[TBL] [Abstract][Full Text] [Related]
19. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
20. SASH1 inhibits cervical cancer cell proliferation and invasion by suppressing the FAK pathway.
Chen H; Wang D; Liu Y
Mol Med Rep; 2016 Apr; 13(4):3613-8. PubMed ID: 26935246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
